Shopping Cart
Remove All
Your shopping cart is currently empty
D-JBD19 TFA is a non-permeable peptide with neuroprotective effects.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 mg | Inquiry | Inquiry | Inquiry | |
| 500 mg | Inquiry | Inquiry | Inquiry |
| Description | D-JBD19 TFA is a non-permeable peptide with neuroprotective effects. |
| In vitro | D-JBD19 is a non-permeable peptide corresponding to dJNKi peptide [1]. |
| In vivo | As compared with D-JNKI1, neuroprotective effects of D-JBD19 against middle cerebral artery occlusion. 15.7 ng of either D-JBD19 or D-JNKI1 or 1570 ng of D-JBD19 are injected i.c.v. just after the ischemia. Animals were killed 24 h later. 100 times more D-JBD19 is needed to provide protection than with D-JNKI1 [2]. |
| Synonyms | D-JBD19 TFA |
| Molecular Weight | 2364.58 |
| Formula | C101H165F3N32O30 |
| Relative Density. | no data available |
| Sequence | H-D-Asp-D-Gln-D-Ser-D-Arg-D-Pro-D-Val-D-Gln-D-Pro-D-Phe-D-Leu-D-Asn-D-Leu-D-Thr-D-Thr-D-Pro-D-Arg-D-Lys-D-Pro-D-Arg-OH |
| Sequence Short | DQSRPVQPFLNLTTPRKPR |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.